8-K 1 q1fy20earningsrelease.htm 8-K Document


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
_____________________________ 
FORM 8-K
 _____________________________ 
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): August 20, 2019
 _____________________________ 
Medtronic Public Limited Company
(Exact name of Registrant as Specified in its Charter)
  _____________________________ 
 
Ireland
 
1-36820
 
98-1183488
(State or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(IRS Employer
Identification No.)
                
20 On Hatch, Lower Hatch Street
Dublin 2, Ireland
(Address of principal executive offices)
+353 1 438-1700
(Registrant's telephone number; including area code):
Not Applicable
Former name or former address, if changed since last report
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))













Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading Symbol
Name of each exchange on which registered
Ordinary shares, par value $0.0001 per share
MDT
New York Stock Exchange, Inc.
Floating Rate Notes due 2021
MDT/21
New York Stock Exchange, Inc.
0% Senior Notes due 2021
MDT/21A
New York Stock Exchange, Inc.
0.00% Senior Notes due 2022
MDT/22B
New York Stock Exchange, Inc.
0.375% Senior Notes due 2023
MDT/23B
New York Stock Exchange, Inc.
0.25% Senior Notes due 2025
MDT/25
New York Stock Exchange, Inc.
1.125% Senior Notes due 2027
MDT/27
New York Stock Exchange, Inc.
1.625% Senior Notes due 2031
MDT/31
New York Stock Exchange, Inc.
1.00% Senior Notes due 2031
MDT/31A
New York Stock Exchange, Inc.
2.250% Senior Notes due 2039
MDT/39A
New York Stock Exchange, Inc.
1.50% Senior Notes due 2039
MDT/39B
New York Stock Exchange, Inc.
1.75% Senior Notes due 2049
MDT/49
New York Stock Exchange, Inc.

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o






Item 2.02.
Results of Operations and Financial Condition

On August 20, 2019, Medtronic plc, a public limited company organized under the laws of Ireland, issued a press release announcing its first quarter fiscal year 2020 financial results. A copy of the press release is furnished as Exhibit 99.1 to this report.
 
Item 9.01.
      Exhibits.
(d) List of Exhibits
Exhibit Number
  
Description
 
 
  
Press release of Medtronic plc, dated August 20, 2019









SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
MEDTRONIC PUBLIC LIMITED COMPANY
 
 
 
 
 
 
 
 
By
 
/s/ Karen L. Parkhill
Date: August 20, 2019
 
 
 
 
 
Karen L. Parkhill
 
 
 
 
 
 
Executive Vice President and Chief Financial Officer








EXHIBIT INDEX

Exhibit Number
  
Description
 
 
  
Press release of Medtronic plc, dated August 20, 2019